Marlies

Drospirenone/Ethinylestradiol, the active ingredient in Marlies, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH USA supplies Marlies as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this EU‑approved hormonal contraceptive. The company ensures quality through stringent manufacturing standards and regulatory compliance.

Marlies, a combined oral contraceptive, is indicated for hormonal contraception and related menstrual conditions. - Contraception: Prevents pregnancy in women of childbearing potential. - Menstrual cycle regulation: Helps achieve more regular and predictable menstrual bleeding. - Acne improvement: May reduce acne associated with hormonal fluctuations. - Endometriosis symptom relief: Can lessen dysmenorrhea and pelvic pain linked to endometriosis.

Marlies may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of the breasts. - Headache: occasional throbbing or tension‑type pain. - Spotting or breakthrough bleeding: irregular light bleeding between periods. - Mood changes: irritability or mild mood swings. - Weight gain: slight increase in body weight.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism. - Arterial thrombosis: stroke or myocardial infarction. - Severe hypertension: sudden increase in blood pressure. - Liver disorders: jaundice or hepatic dysfunction. - Allergic reactions: rash, itching, or swelling. - Severe depression or suicidal thoughts.

Before prescribing Marlies, clinicians should evaluate individual risk factors and counsel patients on safe use. - Assess cardiovascular risk: review history of thromboembolic events, smoking, and hypertension. - Screen for liver disease: avoid use in active liver dysfunction. - Evaluate migraine history: contraindicated in migraine with aura. - Counsel on smoking cessation: especially for women over 35 years. - Review medication list: avoid concurrent use with strong enzyme inducers. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Marlies can interact with several drug classes, affecting efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): may markedly reduce contraceptive effectiveness. - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Certain antiretrovirals (e.g., protease inhibitors): may alter hormone levels.

Moderate Interactions (Monitor Closely): - Antiepileptic drugs (e.g., phenytoin, phenobarbital): may require additional contraceptive measures. - Herbal supplements (e.g., St. John's wort): can decrease plasma hormone concentrations. - Selective serotonin reuptake inhibitors (SSRIs): monitor for mood changes and rare serotonin syndrome.